Literature DB >> 28470753

Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.

Margaret Lawless1, Roman Gulati2, Maria Tretiakova1.   

Abstract

AIMS: Pathological stage pT1 bladder cancers constitute a clinically heterogeneous group. However, current staging guidelines for superficially invasive cancers do not acknowledge the variability in type and extent of lamina propria invasion in papillary urothelial carcinomas (PUCs), and historically proposed substaging systems showed either high interobserver variation or limited value in predicting patient outcomes. The aim of this study was to reappraise pT1 PUC substaging, with the objective of identifying a novel scheme that is reproducible and prognostically meaningful. METHODS AND
RESULTS: pT1 PUCs diagnosed during 1999-2015 were retrospectively reviewed and characterized as focal invasion confined to the papillary stalk, focal invasion of the tumour base, or extensive invasion of the tumour base. Cases with concurrent flat carcinoma in situ, angiolymphatic invasion, absent muscularis propria or clinically advanced disease were excluded. We calculated cumulative incidence rates of recurrence, progression and death by tumour subtype, and evaluated differential risks by using log-rank tests and Kaplan-Meier curves stratified by type and extent of invasion. Among 62 patients satisfying the inclusion criteria, 22 of 29 patients with base-extensive invasion progressed, whereas four of 13 with base-focal and none of 20 with stalk-only invasion progressed. There was strong evidence that base-extensive patients had a higher risk of progression and death resulting from bladder cancer than base-focal or stalk-only patients (P < 0.0001). However, tumour subtype was not significantly associated with risk of recurrence (P = 0.21).
CONCLUSIONS: We propose an innovative substaging approach for reporting the site and extent of lamina propria invasion in patients with pT1 PUC, allowing patient stratification for risk of progression.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  bladder; papillary urothelial carcinoma; stalk invasion

Mesh:

Year:  2017        PMID: 28470753      PMCID: PMC5552491          DOI: 10.1111/his.13247

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  27 in total

1.  Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series.

Authors:  Simone Bertz; Stefan Denzinger; Wolfgang Otto; Wolf F Wieland; Robert Stoehr; Ferdinand Hofstaedter; Arndt Hartmann
Journal:  Histopathology       Date:  2011-10       Impact factor: 5.087

2.  Does muscularis mucosae invasion in extensively lamina propria-invasive high-grade papillary urothelial carcinoma provide additional prognostic information?

Authors:  Chin-Chen Pan
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

3.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

4.  Neoplastic invasion of the connective stalks in transitional cell papillary tumors (TCPT) of the bladder.

Authors:  A Tommasini-Degna; R Negri
Journal:  Urol Res       Date:  1987

5.  Histopathological analysis of a bladder cancer stalk observed on MRI.

Authors:  W Saito; M Amanuma; J Tanaka; A Heshiki
Journal:  Magn Reson Imaging       Date:  2000-05       Impact factor: 2.546

Review 6.  Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance.

Authors:  Antonio Lopez-Beltran; Liang Cheng
Journal:  Pathology       Date:  2003-12       Impact factor: 5.306

7.  Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder.

Authors:  Stefan Denzinger; Maximilian Burger; Hans-Martin Fritsche; Simone Bertz; Ferdinand Hofstädter; Wolf F Wieland; Arndt Hartmann; Wolfgang Otto
Journal:  Scand J Urol Nephrol       Date:  2009

Review 8.  An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.

Authors:  Girish S Kulkarni; Oliver W Hakenberg; Juergen E Gschwend; George Thalmann; Wassim Kassouf; Ashish Kamat; Alexandre Zlotta
Journal:  Eur Urol       Date:  2009-09-01       Impact factor: 20.096

9.  Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients.

Authors:  A Orsola; L Werner; I de Torres; W Martin-Doyle; C X Raventos; F Lozano; S A Mullane; J J Leow; J A Barletta; J Bellmunt; J Morote
Journal:  Br J Cancer       Date:  2014-12-23       Impact factor: 7.640

10.  Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.

Authors:  Carlo Patriarca; Rodolfo Hurle; Marco Moschini; Massimo Freschi; Piergiuseppe Colombo; Maurizio Colecchia; Lucia Ferrari; Giorgio Guazzoni; Andrea Conti; Giario Conti; Roberta Lucianò; Tiziana Magnani; Renzo Colombo
Journal:  Diagn Pathol       Date:  2016-01-20       Impact factor: 2.644

View more
  1 in total

Review 1.  Bladder Cancer Sample Handling and Reporting: Pathologist's Point of View.

Authors:  Roberta Mazzucchelli; Daniela Marzioni; Giovanni Tossetta; Laura Pepi; Rodolfo Montironi
Journal:  Front Surg       Date:  2021-12-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.